Acquisition-backed growth Invivodata was acquired by ERT, positioning the combined entity as a leading provider of Clinical Outcome Assessments including electronic PROs, ClinROs, and ObsROs. This suggests potential cross-sell opportunities within ERT’s existing client base and a need for integrated solutions that leverage both organizations' strengths.

Integrated platform With ERT as the parent company and Invivodata’s portfolio in PROs and related assessments, there is a clear opportunity to offer end-to-end measurement platforms, combining data capture, analytics, and workflow capabilities to streamline clinical outcomes for sponsors.

Financial readiness Revenue in the 10-25 million range and 13 million in funding indicate a mid-market profile with appetite for growth investments. This suggests readiness for upsell of expanded software licenses, services, and premium support packages.

Small agile team Invivodata operates with a lean team (11-50 employees) which can be a selling point for scalable services, rapid implementation, and hands-on client support, while highlighting the need for additional resources from a partner to scale.

Tech and collaboration Use of Google Workspace and DocuSign points to a modern, cloud-based operating model. This enables easy integration with prospective clients’ systems and positions for selling additional digital workflow enhancements and secure data exchanges.